The coverage of antiretroviral therapy among male adults living with HIV in Angola stood at 36 units in 2023. Over the past decade, this figure has shown a steady increase. Between 2022 and 2023, the coverage rose by approximately 2.86%. Analyzing the past two years from 2021 to 2023, the year-on-year variations were consistent, averaging around 2.94%. Notably, the five-year compound annual growth rate (CAGR) for the period from 2023 onwards is forecasted to be 2.5%, indicating a moderate but stable increase over the coming years, culminating in a 13.16% growth by 2028.
Future trends to watch for include advancements in healthcare infrastructure, increased funding for HIV programs, greater accessibility to antiretroviral medications, and potential societal changes affecting healthcare delivery in Angola.
